Jennifer Friel Goldstein is the Head of Business Development and Strategic Initiatives for Life Science and Healthcare (LSHC) banking at Silicon Valley Bank, a division of First Citizen Bank. In this role, Ms. Goldstein leverages her 20+ year experience financing life sciences innovation to identify market opportunities to connect VC and industry stakeholders to SVB’s clients and prospects.
Since joining SVB in 2012, Ms. Goldstein has held a variety of leadership positions across the bank, where she played key roles in developing SVB’s biotech practice, supporting the expansion into investment banking, and revitalizing the approach to coordinated business development. Most recently, she was a Managing Partner with venture investing firm SVB Capital, where she launched and led its first dedicated Life Sciences investment team. Prior to joining SVB, Ms. Goldstein served as a Director on Pfizer’s venture capital team where she helped lead or co-lead investments into life sciences companies, served as a management consultant at Bain & Co. focused on private equity projects across Europe, and held operational and research roles at Chiron, Genelabs, and Genencor.
Ms. Goldstein graduated magna cum laude with a bachelor’s degree in bioengineering and a master’s degree in biotechnology from the University of Pennsylvania. She also holds an MBA from the Wharton School, where she was named a Joseph Wharton Fellow. Her additional director roles include Venture Forward, Digitalis Commons, Springboard Enterprises, the Women’s Health Innovation Coalition, and the Leukemia & Lymphoma Society in Northern California. Jennifer lives in the Bay Area with her husband and their twin children.